MBX Biosciences, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $54.1M | $45.2M | $75.3M | $223.1M | $39.8M | $29.9M | $49.4M | $132.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $427.9M | $448.5M | $381.5M | $397.5M | $229.2M | $244.3M | $267.3M | $281.2M |
| Property, Plant & Equipment | $4.7M | $3.1M | $2.7M | $2.0M | $1.7M | $1.5M | $1.1M | $1.0M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $435.9M | $452.7M | $385.1M | $400.1M | $231.5M | $245.9M | $268.5M | $282.4M |
| Liabilities | ||||||||
| Accounts Payable | $4.4M | $7.0M | $3.0M | $3.8M | $5.8M | $4.2M | $5.3M | $5.0M |
| Total Current Liabilities | $23.7M | $14.6M | $15.5M | $12.1M | $11.8M | $10.5M | $11.1M | $10.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $26.4M | $14.9M | $15.9M | $12.5M | $12.3M | $10.5M | $11.1M | $11.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-285.1M | $-248.0M | $-224.5M | $-202.4M | $-180.8M | $-161.4M | $-137.5M | $-121.9M |
| Total Stockholders' Equity | $409.5M | $437.8M | $369.2M | $387.5M | $219.2M | $235.4M | $257.4M | $271.4M |